Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|October 27, 2004
Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in GermanyKirsten Fluegge, Sven Supper, Anette Siedler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2005
Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in GermanyKirsten Fluegge, Sven Supper, Anette Siedler, et al.
European Journal of Pediatrics|September 1, 2005
Antibiotic resistance patterns among respiratory pathogens at a German university children's hospital over a period of 10 yearsSandra J Arri, Kirsten Fluegge, Urban Mueller, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Heterogeneity of genotype-phenotype correlation among macrolide-resistant Streptococcus agalactiae isolatesUlrich von Both, Anna Buerckstuemmer, Kirsten Fluegge, et al.
The Pediatric Infectious Disease Journal|August 30, 2008
Molecular epidemiology of invasive neonatal Streptococcus agalactiae isolates in GermanyUlrich von Both, Andrea John, Kirsten Fluegge, et al.
European Journal of Pediatrics|August 19, 2006
Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in a southwestern region of GermanyKirsten Fluegge, Brit Adams, Urban Luetke Volksbeck, et al.
Journal of Clinical Microbiology|May 8, 2003
A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of GermanyUlrich von Both, Michael Ruess, Urban Mueller, et al.
The Pediatric Infectious Disease Journal|July 22, 2011
Genetic differences between invasive and noninvasive neonatal group B streptococcal isolatesKirsten Fluegge, Juliana Wons, Barbara Spellerberg, et al.
Pageof 2